Article
Lung cancer stem cells: The root of resistance.
Cancer letters - 28 Mar 2016
MacDonagh Lauren, Gray Steven G, Breen Eamon, Cuffe Sinead, Finn Stephen P, O'Byrne Kenneth J, Barr Martin P
Abstract excerpt
In the absence of specific treatable mutations, platinum-based chemotherapy remains the gold standard of treatment for lung cancer patients. However, 5-year survival rates remain poor due to the development of resistance and eventual relapse. Resistance to conventional cytotoxic therapies presents a significant clinical challenge in the treatment of this disease. The cancer stem cell (CSC) hypothesis suggests...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
